OBJECTIVE: Uniform histopathologic guidelines were applied to diagnose chorioamnionitis and estimate the accuracy of clinical signs in term parturients. STUDY DESIGN: A retrospective cohort study utilized slides from term parturient placentas with Amniotic Fluid Infection Nosology Committee guidelines as the gold standard. Sensitivity, specificity and accuracy for fever, maternal tachycardia and fetal tachycardia were calculated. RESULT: Of 641 placentas, 367 (57.3%) had histologic chorioamnionitis and 274 (42.7%) were negative. Fever had a sensitivity of 42%, specificity of 86.5% and accuracy of 61%. Fever, maternal tachycardia and fetal tachycardia had a sensitivity of 18.3%, specificity of 98.2% and accuracy of 52.4%. CONCLUSION: Histologic chorioamnionitis, frequently asymptomatic, is a common finding in placentas examined from term parturients. Clinical signs are not accurate in the diagnosis. Adoption of uniform pathologic guidelines will facilitate research into the clinical significance of these lesions in the future.
INTRODUCTION
Histopathology can be considered the gold standard in diagnosing chorioamnionitis. 1 Some studies define clinical chorioamnionitis as fever plus two additional signs. 2, 3 As intrapartum antibiotic treatment of chorioamnionitis improves both fetal and maternal outcomes, 4 in clinical obstetric practice, an intrapartum fever with appropriate risk factors 5 typically prompts administration of intravenous antibiotics. Clinical chorioamnionitis has a reported incidence of 5 to 12% in the term parturient. [5] [6] [7] The individual clinical signs that are used to define clinical chorioamnionitis vary among studies. An intrapartum temperature of 1001F and antibiotics administered for that indication was the only sign required in one study, 6 whereas other studies required an intrapartum temperature 100 to 1011F plus clinical signs that included one or more of the following: maternal tachycardia (4100 b.p.m.), fetal tachycardia (4160 b.p.m.), maternal leukocytosis (variably defined), uterine tenderness and foul-smelling or purulent amniotic fluid. [2] [3] [4] [5] 7 None of these studies correlated clinical signs to placental pathology.
Variations in the criteria for diagnosis of histopathologic chorioamnionitis have been published. [8] [9] [10] [11] [12] [13] In studies reporting a consecutive series of all livebirths, histologic chorioamnionitis was found in 10 to 38% of placentas. 9, 10, 13, 14, 15 It is apparent that histologic chorioamnionitis occurs more frequently than clinically evident chorioamnionitis, even in the term parturient. In one study, only 8.1% of patients with histologic chorioamnionitis were noted to have fever.
14 Lack of standardization in diagnostic terminology for histologic chorioamnionitis may be one reason for the variation in incidence. Redline et al. 16 classified histologic chorioamnionitis into well-defined anatomic stages and grades of inflammation; six expert placental pathologists found approximately 90% agreement for any stage of maternal and fetal inflammatory responses in the placenta. Using these guidelines as the gold standard for histologic chorioamnionitis, we retrospectively reclassified all placentas submitted from term parturients in a single year to determine the sensitivity, specificity and accuracy for the intrapartum signs of fever, maternal tachycardia and fetal tachycardia. We hypothesized that fever, maternal tachycardia and fetal tachycardia would have limited sensitivity in the histopathologic diagnosis of chorioamnionitis.
METHODS
This was a retrospective cohort study of all singleton term livebirths, X37 weeks' gestation, that had placental examination at Strong Memorial Hospital in 2005. The study was approved by the research subjects review board at the University of Rochester Medical Center. Using the birth certificate registry, all term livebirths were identified and cross-referenced with the pathology database to identify which births also had placental examination. Only women admitted with singleton pregnancies in labor or undergoing induction of labor at term who had the placenta submitted for pathologic examination were included as subjects of the study. Although physicians at this institution had previously received education on recommended indications for placental examination, 17 there were no departmental mandates for placental submission and the decision was ultimately that of the attending physician. We excluded patients undergoing elective primary or repeat cesarean section in the absence of labor.
Placentas had been processed according to standard guidelines. 17 A membrane roll, two sections from the placental disc and one or two cord sections were available for review from each placenta. The original histopathologic slides of the placenta were interpreted by one of two perinatal pathologists (PJK and LAM) at the time of placental submission in 2005. All slides from subjects fulfilling the study entry criteria were retrieved in 2007 to 2008. They were rescreened by a third pathologist (WMC) and categorized according to the absence or presence of inflammation. The inflammation was staged and graded according to the criteria of Redline et al. 16 Briefly, this is a three-stage, two-grade classification for maternal and fetal inflammatory responses, the details of which are given in the Supplementary Box. Slides with placental inflammation were again reviewed concurrently with PJK for final classification, and if there was uncertainty with classification LAM was consulted. All slides were reviewed without clinical information. Cohorts were divided into two groups according to the presence or absence of histologic chorioamnionitis. Histologic chorioamnionitis was considered to be any stage and grade of maternal inflammatory response that fulfilled the guidelines. The presence of any fetal inflammatory responses in the umbilical cord and placenta was also classified.
Maternal, intrapartum and neonatal data were retrieved from the intrapartum electronic record (QS; GE Healthcare, Barrington, IL, USA). The hospital computerized medical records were also reviewed for discharge summaries, operative reports, placental pathology reports and discharge coding summaries. Paper charts were retrieved if additional data were needed. The following maternal data were collected: age, parity, race/ ethnicity, gestational age, group B streptococcus (GBS) status and whether or not there was induction of labor. Intrapartum data included epidural use, the number of vaginal examinations, use of internal monitoring and amnioinfusion, presence of particulate meconium and severe variable decelerations (defined as X60 b.p.m. decrease from the baseline lasting X60 s), use of intrapartum antibiotics, duration of labor and ruptured membranes and mode of delivery. Placental pathology reports were reviewed for the original indications that lead to submission of the placenta for examination. The newborn data collected included birthweight, Apgar scores, placental weight and whether there was observation for sepsis, the latter determined by review of the coding summary at newborn discharge or blood cultures taken during the newborn admission.
Comparisons of cohorts with and without histologic chorioamnionitis and with and without fetal inflammatory response (of any stage) were made. Categorical data were analyzed with w 2 tests of association and continuous data with t-tests as appropriate. Odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated as appropriate. Forward stepwise multiple logistic regression was used to identify independent clinical predictors of histologic chorioamnionitis and fetal inflammatory response at any stage. Significance was set at Pp0.05 and no corrections were made for multiple comparisons. Statistical analysis was performed using SPSS for Windows (SPSS, Chicago, IL, USA).
The clinical signs evaluated for diagnostic accuracy were fever, maternal tachycardia and fetal tachycardia. Fever was defined as a maternal temperature X38 1C, maternal tachycardia as a pulse X120 b.p.m. and fetal tachycardia as a sustained (X10 min) baseline fetal heart rate of X160 b.p.m. The sensitivity, specificity and accuracy and their 95% CI were calculated for histologic chorioamnionitis of any stage. We chose a higher cutoff for maternal tachycardia during labor as approximately 80% of subjects had at least one heart rate X100 b.p.m. We did not evaluate maternal white blood cell counts as these were not uniformly available for all patients. We also did not evaluate the subjective signs of uterine tenderness or foul-smelling amniotic fluid as these signs would only expected to be documented on those subjects clinically suspected to have infection.
We used published nomograms to estimate the necessary sample size. 18 Using a data set from a previous study, 19 we estimated a prevalence of histologic chorioamnionitis of 30%, a sensitivity of fever of 50% with a CI of 10% and a ¼ 0.05 to give a sample size of approximately 400 subjects. The specificity of fever for histologic chorioamnionitis was hypothesized to be 88% with a CI of 5% and a ¼ 0.05 to give an approximate sample size of 200. We used the Standards for Reporting of Diagnostic Accuracy guidelines for this study. 20 
RESULTS
There were 713 term singleton births with placental examination out of a total of 2700 births in 2005; 72 births were excluded as the mothers were not laboring, leaving a total of 641 subjects. The total number of term parturients was approximately 2124; thus, the percentage of placentas examined from term parturients was 30%. They were divided into two cohorts for comparison: 367 (57.3%) in which histologic chorioamnionitis was present and 274 in which (42.7%) it was absent. The indications listed on the 641 placental requisitions by the delivering clinician are categorized and summarized as follows: suspected chorioamnionitis, 158; medical complication of pregnancy, 110; placental abnormality or bleeding, 83; meconium, 76; fetal growth or amniotic fluid abnormality, 58; and other, 103. Intrapartum fever or suspected chorioamnionitis was much more likely to be listed on the requisition as the indication for placental examination by the clinician in the cohort that had histologic chorioamnionitis (134 (36.5%) vs 24 (8.8%); OR 6.0; 95% CI: 3.8 to 9.5). The classification of the 367 placentas with histologic chorioamnionitis by stage and grade is given in Table 1 . Fetal inflammatory responses were noted in 114 (31%) of the 367 cases with histologic chorioamnionitis, but in no cases among the 274 placentas without histologic chorioamnionitis (OR 123; 95% CI: 21.4 to 705). The classification of the 114 cases of fetal inflammatory response by stage and grade is shown in Table 2 . Fetal inflammatory responses were more likely to occur with increasing stage of histologic chorioamnionitis: stage 1, 7.6%; stage 2, 48.1%; and stage 3, 93%; Po0.001.
The demographic and intrapartum characteristics of the cohorts with and without histologic chorioamnionitis are given in Table 3 . The frequency of intrapartum signs overall and stratified by stage of histologic chorioamnionitis is compared in Table 4 . All signs were significantly more often associated with histologic chorioamnionitis overall when compared with no histologic chorioamnionitis. It is also noted that intrapartum fever was more often associated with stage 2 and stage 3 histologic chorioamnionitis than stage 1. Maternal tachycardia was only significantly associated with stage 2 and 3 histologic chorioamnionitis. Fetal tachycardia was significantly associated with all three stages of histologic chorioamnionitis with no significant difference noted among all three stages. The sensitivity, specificity and accuracy of clinical signs in prediction of histologic chorioamnionitis of any stage are given in Table 5 . Newborn outcomes are compared in Table 6 .
Forward stepwise logistic regression analysis was performed with histologic chorioamnionitis as the outcome variable and the following included as dichotomous independent variables: parity X1, GBS status, induction of labor, epidural, internal monitoring, amnioinfusion, particulate meconium, fever, maternal tachycardia, fetal tachycardia, severe variable decelerations and 1 min Apgar p6. The following were included as continuous independent variables: gestational age, number of vaginal exams, duration of labor, duration of ruptured membranes and birthweight. The results of the multiple logistic regression for independent predictors of histologic chorioamnionitis are given in Table 7 . Cohorts were compared with (n ¼ 114) and without fetal inflammatory responses (n ¼ 527) and the maternal demographic and intrapartum characterisitcs results are given in Table 8 . The frequency of intrapartum signs overall and stratified by stage of fetal inflammatory response is compared in Table 9 . All signs were significantly more often associated with fetal inflammatory It is also noted that maternal tachycardia was more often associated with stage 2 or greater fetal inflammatory response when compared with stage 1. Newborns in the cohort with fetal inflammatory response were more likely to have 1-min Apgar scores p6, a higher frequency of observation for sepsis and all placentas also showed histologic chorioamnionitis (Table 10) . Forward stepwise logistic regression analysis was performed with fetal inflammatory response as the outcome variable and the following included as dichotomous independent variables: parity X1, GBS status, induction of labor, epidural, internal monitoring, particulate meconium, amnioinfusion, fever, maternal tachycardia, fetal tachycardia, severe variable decelerations and 1-min Apgar p6. The following were included as continuous independent variables: gestational age, number of vaginal exams, duration of labor, duration of ruptured membranes and birthweight. The results of the multiple logistic regression for independent predictors of fetal inflammatory response are given in Table 11 .
DISCUSSION
Histologic chorioamnionitis was a common finding, present in 57% of term placentas submitted for examination. Approximately one-third of these placentas also had a fetal inflammatory response. Only 42% of women had an intrapartum fever. The clinical signs (fever, maternal tachycardia, fetal tachycardia) were strongly associated with histologic chorioamnionitis but were diagnostically insensitive. The strength of this study was the large numbers of term parturients and their placentas included in the analysis and the uniform application of standard histopathologic staging and grading criteria. The results of this study would be expected to be generalizable to similar populations of patients. The retrospective nature of the study would be a weakness. The prevalence of histologic chorioamnionitis was high in this study as the study was predicated on the submission of the placenta for examination and the clinician was more likely to submit the placenta when there was a clinical suspicion for chorioamnionitis. Of 2124 term parturient placentas, 30% were submitted for examination. While this is a sizable portion of placentas, it is not a random sample and therefore subject to bias. Clinicians are more likely to submit the placenta for examination when chorioamnionitis is suspected and this may be an explanation for the high rate of histologic chorioamnionitis and fever in our study. We do not know our true population prevalence of histologic chorioamnionitis from our term parturients, and thus could not offer reliable estimates of positive predictive value and negative predictive value for clinical signs. The sensitivity, specificity and accuracy of clinical signs are not affected by prevalence, and thus these calculated values are valid estimates. The prevalence of histologic chorioamnionitis and funisitis in one prospective study of term parturients was reported as 23.6% and 6.7%, respectively. 21 A hypothetical positive predictive value and negative predictive value for fever in our total population of 2124 term parturients is calculated as follows: a hypothesized prevalence of disease (histologic chorioamnionitis) of 24% for the remaining 1483 term parturients who did not have the placenta examined with a 13.5% false-positive rate and a 58% false-negative rate added to the existing data for our 641 term parturients with placental examination would give a positive predictive value of 61.7% (95% CI: 57.2 to 66.0) and a negative predictive value of 74.3% (95% CI: 72.1 to 76.4). If we had chosen a cutoff for histologic chorioamnionitis that was more severe (for example, Xstage 2) in this study, minor changes in sensitivity and specificity would be expected with a decline in prevalence of disease and a concomitant decrease in the positive predictive value and an increase in the negative predictive value.
This study included only term pregnancies in labor to assess the accuracy of clinical signs using histologic chorioamnionitis as the gold standard and may be unique in that respect. One study that included both term and preterm deliveries with a discharge diagnosis of clinical chorioamnionitis did not find a difference in intrapartum fever, or maternal tachycardia and fetal tachycardia between groups with and without histologic chorioamnionitis. 22 Heller et al. 23 also studied term and preterm deliveries with and without histologic chorioamnionitis and found no significant differences in the proportion with intrapartum fever. In our study, the overall incidence of intrapartum fever was approximately 30%. Intrapartum fever does not necessarily mean infection from chorioamnionitis, but there is currently no way to distinguish between infectious and noninfectious fever in labor. Epidural anesthesia is associated with fever and there was a high rate of epidural use in this study. The incidence of fever in women receiving intrapartum epidural anesthesia ranges from approximately 2 to 46%. 24 Of note in our study is that fetal inflammatory responses did not occur in the absence of histologic chorioamnionitis. This finding is in agreement with the view that a fetal inflammatory response is a sequela to maternal histologic chorioamnionitis and seldom seen in isolation. 8 Detection of histologic chorioamnionitis may be improved with increasing samples of extraplacental membranes. 25 We did not find an association by multivariate analysis between particulate meconium or severe variable decelerations and histologic chorioamnionitis and fetal inflammatory responses as other authors have found. [26] [27] [28] We also did not find any significant association with histologic chorioamnionitis when meconium staining was listed as an indication on the requisition nor was there any significant association between the histologic presence of meconium and histologic chorioamnionitis (data not shown). The reason why advancing gestational age and induction of labor are independent, positive and negative predictors, respectively, of histologic chorioamnionitis is unclear. Park et al. 29 also reported these findings in their study of term parturients. An explanation in the case of advancing gestational age may be that the physical barrier to ascending infection may be decreased through loss of the mucus plug or cervical dilation. The association with induction of labor may be related to an unripe cervix as an effective barrier, qualitative differences in labor or the possibility that some cases of term spontaneous labor are initiated by intrauterine infection.
In summary, while intrapartum clinical signs are significantly associated with histopathologic chorioamnionitis and fetal inflammatory responses, they lack diagnostic accuracy. It is therefore possible to have pathologically significant inflammatory lesions in the placenta with no intrapartum signs, as well as an asymptomatic newborn. The short-and long-term consequences of this discrepancy are not clear. Chorioamnionitis at term has been associated with cerebral palsy. Cerebral palsy had a prevalence of 0.67 per 1000 singleton births of normal birth weight surviving to age 3 in one study. 30 Maternal infection was found to be a risk factor for cerebral palsy overall and histologic chorioamnionitis, as a subcategory of maternal infection, was associated with an increased risk of unexplained spastic cerebral palsy (OR 8.9; 95% CI: 1.9 to 40). Of particular note in this study was the fact that most infants born to infected women did not have recognized neonatal infection in the newborn period. The authors estimated that the attributable risk of infection to total spastic cerebral palsy was 12% in children of normal birth weight. Wu and Colford 31 reported that clinical chorioamnionitis was associated with an increased risk of cerebral palsy in preterm and term infants; they pointed out the crucial need to develop consensus definitions for histologic chorioamniontis as uniform definitions would likely strengthen the relationship. The stage and grade of histologic chorioamnionitis and fetal inflammatory responses associated with cerebral palsy is an area in need of further study. One case-control study noted that only severe fetal responses to maternal infection were statistically associated with neurologic impairment following term birth. 32 Elucidation of the relationship between stage and grade of histologic chorioamnionitis and fetal inflammatory responses and short-term neonatal outcomes, for example, readmission for neonatal sepsis and long-term outcomes, such as cerebral palsy, will necessarily rest on a firm foundation of standard and uniform histopathologic diagnosis. 
